Home » Newsletters » BioWorld Science

BioWorld Science

June 20, 2007

View Archived Issues

Recent clinical data on nilotinib in leukemia presented

Snapshots of agents under study in Alzheimer's disease

Malaria vaccine AMA1 studied in phase Ib trial in Mali

New results with therapies under development for Parkinson's disease

Recent Tibotec and Bristol-Myers Squibb patents report novel therapeutic agents for HIV infection

New agents for treating neurological disorders disclosed in recent patent literature

Recent patents report novel therapeutic agents for metabolic disorders

NOV-002 slows disease progression in platinum-resistant ovarian cancer

Positive topline findings for balsalazide tablets

FDA grants orphan drug status to Immtech's pafuramidine

Keryx completes patient randomization for Sulonex phase III study

Chugai to explore safety of oseltamivir

Findings for new powder form of Renvela

IC31 adjuvanted flu vaccine begins phase I trials

Lexicon announces long-term financial agreements with Invus and Symphony

Peptech restructures agreement with Biosceptre

Sativex receives Qualifying Notice from Health Canada for cancer pain

Genta to request review of Genasense's non-approvable status

Collegium files IND for abuse deterrent opioid COL-003

Terutroban exhibits beneficial effects in rat models of stroke

FDA accepts for review GlaxoSmithKline's DTaP-IPV combination vaccine

Preclinical studies on drugs under development for Parkinson's disease

Telcyta clinical hold converted to partial hold

Nexavar submitted in E.U. for hepatocellular carcinoma

Ixabepilone NDA granted priority review

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 24, 2024.
Enhanced Cognition: Lewy body dementia phase II pumps stock
BioWorld
Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...
Experimental mRNA gene therapy suppresses preeclampsia in mice
BioWorld MedTech
A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...
Probing bidirectional cancer-autoimmune link can yield new targets
BioWorld Science
Cancer and autoimmunity are “often thought of as being at opposite ends of the immune response,” Ana Anderson told her audience at a joint meeting of the NIH’s...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.